SCHEMBL2202827

SCHEMBL2202827

CCC(C(N)=O)(c1ccccc1)c1ccncc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRM3 P20309 4/20 0.47
KCNH2 Q12809 3/20 0.47
CHRM2 P08172 2/20 0.47
CHRM1 P11229 2/20 0.47
CYP2D6 P10635 2/20 0.47
LMNA P02545 1/20 0.47
MAPT P10636 1/20 0.46
KMT2A Q03164 1/20 0.46
KIF11 P52732 2/20 0.46
KDM4E B2RXH2 1/20 0.46
CTDSP1 Q9GZU7 1/20 0.46
OPRK1 P41145 2/20 0.45
CYP3A4 P08684 2/20 0.45
SLC22A2 O15244 1/20 0.45
SLC22A1 O15245 1/20 0.45
PGR P06401 1/20 0.45
THRB P10828 1/20 0.45
ADRB3 P13945 1/20 0.45
BLM P54132 1/20 0.45
PMP22 Q01453 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4030430 0.89 MAPT (0.55) CHRM3KCNH2CHRM2CHRM1CYP2D6
Hydrochloric Acid SCHEMBL5252883 0.88 MAPT (0.53) CHRM3KCNH2CHRM2CHRM1CYP2D6
SCHEMBL2205198 0.87 CHRM3 (0.51) CHRM3KCNH2CHRM2CHRM1CYP2D6
SCHEMBL2201632 0.82 KDM4E (0.43) CHRM3KCNH2CHRM2CHRM1CYP2D6
SCHEMBL17596757 0.80 CYP3A4 (0.47) LMNACYP3A4TDP1PLOD2PLOD3
SCHEMBL2202450 0.77 KMT2A (0.55) CHRM3CHRM2CHRM1CYP2D6MAPT
SCHEMBL9989231 0.77 CHRM3 (0.42) CHRM3KCNH2CHRM2CHRM1CYP2D6
SCHEMBL17439469 0.76 KMT2A (0.46) CHRM3KCNH2CHRM2CHRM1CYP2D6
SCHEMBL9295790 0.75 CHRM3 (0.59) CHRM3KCNH2CHRM2CHRM1CYP2D6
SCHEMBL28232039 0.75 KDM4E (0.42) CHRM3KCNH2CHRM2CHRM1CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110166132-A1 Gamma Secretase Modulators AMGEN INC. (US) 2011-07-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110166132-A1 Gamma Secretase Modulators BACE1, BACE2, PSEN1 CHRM3 1829/4885KCNH2 4513/4885CHRM2 2264/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.